Long-Term Efficacy and Safety of Sodium Channel Antagonists in Patients With p.R222Q SCN5A-Related Arrhythmic Dilated Cardiomyopathy

Authors:
  • SPStacey Peters
    Stacey Peters
  • RJRenee Johnson
    Renee Johnson
  • DZDominica Zentner
    Dominica Zentner
  • PJPaul James
    Paul James
  • JKJonathan M. Kalman
    Jonathan M. Kalman
  • DFDiane Fatkin
    Diane Fatkin

Abstract
No abstract available
Funding Information
  • National Health and Medical Research Council
  • NSW Health
  • Victor Chang Cardiac Research Institute
  • Melbourne Institute, University of Melbourne